Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model

Yong T. Shin, David H. Adams, Lauri R. Wyner, Enver Akalin, Mohamed H. Sayegh, Morris J. Karnovsky

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Successful induction of donor-specific unresponsiveness by intrathymic inoculation of alloantigen in several experimental acute rejection models has led us to hypothesize that similar immune manipulations can prevent chronic rejection and development of graft arteriosclerosis in the Lewis-to-F344 rat chronic cardiac allograft rejection model. Recipient F344 rats were treated with donor (Lewis) splenocytes by intrathymic injection (i.t.) alone (10×10<sup>6</sup> cells/lobe); with donor splenocytes i.t. plus a one-time dose of ALS (1 mg) by intraperitoneal injection (i.p.); or with ALS i.p. (1 mg) alone 2 and 6 weeks prior to heterotopic Lewis heart transplantation. Control F344 recipients received saline i.t. Allografts were monitored by daily palpation, and long-term surviving grafts were harvested on day 90 for histopathologic analysis. Control allografts had 28.6% long-term survival (>90 days) with mean graft survival of 46.7±12.2 days. At day 90 the surviving control allografts were enlarged and fibrotic with barely palpable heartbeat (mean heartbeat grade 0.29±0.18), and histologically showed diffuse moderate mononuclear cell infiltrates and advanced graft arteriosclerosis (mean vessel score 3.57±0.10 and 89±1% vessels diseased). Recipient treatment with intrathymic donor splenocytes alone significantly prolonged graft survival (89% long-term survival; mean 83.8±6.2 days, P<0.04), but did not significantly inhibit the development of graft arteriosclerosis (score 2.98±0.53 and 79±8% diseased, P=NS). By contrast, treatment with i.t. donor splenocytes plus ALS 2 weeks prior to transplantation prolonged graft survival (100% long-term; mean 90.0±0.0 days, P<0.04), and markedly inhibited graft arteriosclerosis (score 0.80±0.14, P<0.05; 27±4% diseased, P<0.05). ALS alone given two weeks prior to transplantation also prolonged graft survival (100% long-term; mean 90.0±0.0 days, P<0.04), and inhibited graft arteriosclerosis(score 0.89±0.31, P<0.05; 25±7% diseased, P<0.05). Howerver, when ALS was given 6 weeks prior to heart transplantaion the beneficial effect of ALS alone was abolished, suggested that lymphocyte depletion may have been responsible for the observed effects when ALS was administered at 2 weeks. Interestingly, intrathymic donor splenocytes plus ALS given 6 weeks prior to transplantation, on the other hand, showed significant prolongation of allograft survival (100% long-term, mean 90.0±0.0 days, P<0.04), and inhibited graft arteriosclerosis (score 0.41±0.02, P<0.05; 16±12% diseased, P<0.05). Our results indicate the importance of the cell-mediated immune response in initiating and mediating development of chronic rejection and graft ateriosclerosis, and suggest that strategies aimed at induction of tolerance may be effective in their prevention.

Original languageEnglish (US)
Pages (from-to)1647-1653
Number of pages7
JournalTransplantation
Volume59
Issue number12
StatePublished - Jun 27 1995
Externally publishedYes

Fingerprint

Arteriosclerosis
Allografts
Graft Survival
Transplants
Injections
Transplantation
Inbred F344 Rats
Graft Rejection
Intraperitoneal Injections
Lymphocyte Depletion
Isoantigens
Palpation
Heart Transplantation
Therapeutics

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Shin, Y. T., Adams, D. H., Wyner, L. R., Akalin, E., Sayegh, M. H., & Karnovsky, M. J. (1995). Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. Transplantation, 59(12), 1647-1653.

Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. / Shin, Yong T.; Adams, David H.; Wyner, Lauri R.; Akalin, Enver; Sayegh, Mohamed H.; Karnovsky, Morris J.

In: Transplantation, Vol. 59, No. 12, 27.06.1995, p. 1647-1653.

Research output: Contribution to journalArticle

Shin, YT, Adams, DH, Wyner, LR, Akalin, E, Sayegh, MH & Karnovsky, MJ 1995, 'Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model', Transplantation, vol. 59, no. 12, pp. 1647-1653.
Shin YT, Adams DH, Wyner LR, Akalin E, Sayegh MH, Karnovsky MJ. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. Transplantation. 1995 Jun 27;59(12):1647-1653.
Shin, Yong T. ; Adams, David H. ; Wyner, Lauri R. ; Akalin, Enver ; Sayegh, Mohamed H. ; Karnovsky, Morris J. / Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. In: Transplantation. 1995 ; Vol. 59, No. 12. pp. 1647-1653.
@article{03ff4a48ae484e9f9d42f6e44d29d535,
title = "Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model",
abstract = "Successful induction of donor-specific unresponsiveness by intrathymic inoculation of alloantigen in several experimental acute rejection models has led us to hypothesize that similar immune manipulations can prevent chronic rejection and development of graft arteriosclerosis in the Lewis-to-F344 rat chronic cardiac allograft rejection model. Recipient F344 rats were treated with donor (Lewis) splenocytes by intrathymic injection (i.t.) alone (10×106 cells/lobe); with donor splenocytes i.t. plus a one-time dose of ALS (1 mg) by intraperitoneal injection (i.p.); or with ALS i.p. (1 mg) alone 2 and 6 weeks prior to heterotopic Lewis heart transplantation. Control F344 recipients received saline i.t. Allografts were monitored by daily palpation, and long-term surviving grafts were harvested on day 90 for histopathologic analysis. Control allografts had 28.6{\%} long-term survival (>90 days) with mean graft survival of 46.7±12.2 days. At day 90 the surviving control allografts were enlarged and fibrotic with barely palpable heartbeat (mean heartbeat grade 0.29±0.18), and histologically showed diffuse moderate mononuclear cell infiltrates and advanced graft arteriosclerosis (mean vessel score 3.57±0.10 and 89±1{\%} vessels diseased). Recipient treatment with intrathymic donor splenocytes alone significantly prolonged graft survival (89{\%} long-term survival; mean 83.8±6.2 days, P<0.04), but did not significantly inhibit the development of graft arteriosclerosis (score 2.98±0.53 and 79±8{\%} diseased, P=NS). By contrast, treatment with i.t. donor splenocytes plus ALS 2 weeks prior to transplantation prolonged graft survival (100{\%} long-term; mean 90.0±0.0 days, P<0.04), and markedly inhibited graft arteriosclerosis (score 0.80±0.14, P<0.05; 27±4{\%} diseased, P<0.05). ALS alone given two weeks prior to transplantation also prolonged graft survival (100{\%} long-term; mean 90.0±0.0 days, P<0.04), and inhibited graft arteriosclerosis(score 0.89±0.31, P<0.05; 25±7{\%} diseased, P<0.05). Howerver, when ALS was given 6 weeks prior to heart transplantaion the beneficial effect of ALS alone was abolished, suggested that lymphocyte depletion may have been responsible for the observed effects when ALS was administered at 2 weeks. Interestingly, intrathymic donor splenocytes plus ALS given 6 weeks prior to transplantation, on the other hand, showed significant prolongation of allograft survival (100{\%} long-term, mean 90.0±0.0 days, P<0.04), and inhibited graft arteriosclerosis (score 0.41±0.02, P<0.05; 16±12{\%} diseased, P<0.05). Our results indicate the importance of the cell-mediated immune response in initiating and mediating development of chronic rejection and graft ateriosclerosis, and suggest that strategies aimed at induction of tolerance may be effective in their prevention.",
author = "Shin, {Yong T.} and Adams, {David H.} and Wyner, {Lauri R.} and Enver Akalin and Sayegh, {Mohamed H.} and Karnovsky, {Morris J.}",
year = "1995",
month = "6",
day = "27",
language = "English (US)",
volume = "59",
pages = "1647--1653",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model

AU - Shin, Yong T.

AU - Adams, David H.

AU - Wyner, Lauri R.

AU - Akalin, Enver

AU - Sayegh, Mohamed H.

AU - Karnovsky, Morris J.

PY - 1995/6/27

Y1 - 1995/6/27

N2 - Successful induction of donor-specific unresponsiveness by intrathymic inoculation of alloantigen in several experimental acute rejection models has led us to hypothesize that similar immune manipulations can prevent chronic rejection and development of graft arteriosclerosis in the Lewis-to-F344 rat chronic cardiac allograft rejection model. Recipient F344 rats were treated with donor (Lewis) splenocytes by intrathymic injection (i.t.) alone (10×106 cells/lobe); with donor splenocytes i.t. plus a one-time dose of ALS (1 mg) by intraperitoneal injection (i.p.); or with ALS i.p. (1 mg) alone 2 and 6 weeks prior to heterotopic Lewis heart transplantation. Control F344 recipients received saline i.t. Allografts were monitored by daily palpation, and long-term surviving grafts were harvested on day 90 for histopathologic analysis. Control allografts had 28.6% long-term survival (>90 days) with mean graft survival of 46.7±12.2 days. At day 90 the surviving control allografts were enlarged and fibrotic with barely palpable heartbeat (mean heartbeat grade 0.29±0.18), and histologically showed diffuse moderate mononuclear cell infiltrates and advanced graft arteriosclerosis (mean vessel score 3.57±0.10 and 89±1% vessels diseased). Recipient treatment with intrathymic donor splenocytes alone significantly prolonged graft survival (89% long-term survival; mean 83.8±6.2 days, P<0.04), but did not significantly inhibit the development of graft arteriosclerosis (score 2.98±0.53 and 79±8% diseased, P=NS). By contrast, treatment with i.t. donor splenocytes plus ALS 2 weeks prior to transplantation prolonged graft survival (100% long-term; mean 90.0±0.0 days, P<0.04), and markedly inhibited graft arteriosclerosis (score 0.80±0.14, P<0.05; 27±4% diseased, P<0.05). ALS alone given two weeks prior to transplantation also prolonged graft survival (100% long-term; mean 90.0±0.0 days, P<0.04), and inhibited graft arteriosclerosis(score 0.89±0.31, P<0.05; 25±7% diseased, P<0.05). Howerver, when ALS was given 6 weeks prior to heart transplantaion the beneficial effect of ALS alone was abolished, suggested that lymphocyte depletion may have been responsible for the observed effects when ALS was administered at 2 weeks. Interestingly, intrathymic donor splenocytes plus ALS given 6 weeks prior to transplantation, on the other hand, showed significant prolongation of allograft survival (100% long-term, mean 90.0±0.0 days, P<0.04), and inhibited graft arteriosclerosis (score 0.41±0.02, P<0.05; 16±12% diseased, P<0.05). Our results indicate the importance of the cell-mediated immune response in initiating and mediating development of chronic rejection and graft ateriosclerosis, and suggest that strategies aimed at induction of tolerance may be effective in their prevention.

AB - Successful induction of donor-specific unresponsiveness by intrathymic inoculation of alloantigen in several experimental acute rejection models has led us to hypothesize that similar immune manipulations can prevent chronic rejection and development of graft arteriosclerosis in the Lewis-to-F344 rat chronic cardiac allograft rejection model. Recipient F344 rats were treated with donor (Lewis) splenocytes by intrathymic injection (i.t.) alone (10×106 cells/lobe); with donor splenocytes i.t. plus a one-time dose of ALS (1 mg) by intraperitoneal injection (i.p.); or with ALS i.p. (1 mg) alone 2 and 6 weeks prior to heterotopic Lewis heart transplantation. Control F344 recipients received saline i.t. Allografts were monitored by daily palpation, and long-term surviving grafts were harvested on day 90 for histopathologic analysis. Control allografts had 28.6% long-term survival (>90 days) with mean graft survival of 46.7±12.2 days. At day 90 the surviving control allografts were enlarged and fibrotic with barely palpable heartbeat (mean heartbeat grade 0.29±0.18), and histologically showed diffuse moderate mononuclear cell infiltrates and advanced graft arteriosclerosis (mean vessel score 3.57±0.10 and 89±1% vessels diseased). Recipient treatment with intrathymic donor splenocytes alone significantly prolonged graft survival (89% long-term survival; mean 83.8±6.2 days, P<0.04), but did not significantly inhibit the development of graft arteriosclerosis (score 2.98±0.53 and 79±8% diseased, P=NS). By contrast, treatment with i.t. donor splenocytes plus ALS 2 weeks prior to transplantation prolonged graft survival (100% long-term; mean 90.0±0.0 days, P<0.04), and markedly inhibited graft arteriosclerosis (score 0.80±0.14, P<0.05; 27±4% diseased, P<0.05). ALS alone given two weeks prior to transplantation also prolonged graft survival (100% long-term; mean 90.0±0.0 days, P<0.04), and inhibited graft arteriosclerosis(score 0.89±0.31, P<0.05; 25±7% diseased, P<0.05). Howerver, when ALS was given 6 weeks prior to heart transplantaion the beneficial effect of ALS alone was abolished, suggested that lymphocyte depletion may have been responsible for the observed effects when ALS was administered at 2 weeks. Interestingly, intrathymic donor splenocytes plus ALS given 6 weeks prior to transplantation, on the other hand, showed significant prolongation of allograft survival (100% long-term, mean 90.0±0.0 days, P<0.04), and inhibited graft arteriosclerosis (score 0.41±0.02, P<0.05; 16±12% diseased, P<0.05). Our results indicate the importance of the cell-mediated immune response in initiating and mediating development of chronic rejection and graft ateriosclerosis, and suggest that strategies aimed at induction of tolerance may be effective in their prevention.

UR - http://www.scopus.com/inward/record.url?scp=0029074198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029074198&partnerID=8YFLogxK

M3 - Article

VL - 59

SP - 1647

EP - 1653

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 12

ER -